Jul 13, 2026 04:01PM
Jun 14, 2026 04:35PM
Jun 14, 2026 04:35PM
Jun 11, 2026 04:01PM
Jun 4, 2026 08:06AM
Jun 4, 2026 08:05AM
Jun 1, 2026 02:53AM Mirum presents new data on rare liver disease treatments at EASL congress
May 30, 2026 12:00PM
May 21, 2026 08:05AM
May 19, 2026 05:33AM
May 14, 2026 04:01PM
May 12, 2026 11:56PM
May 12, 2026 11:56PM
May 12, 2026 04:01PM Mirum announces $600 million convertible notes offering due 2032
May 12, 2026 04:01PM
May 12, 2026 08:00AM
May 6, 2026 04:01PM
May 4, 2026 08:01AM
May 4, 2026 08:00AM
Apr 27, 2026 08:00AM
Apr 27, 2026 08:00AM Mirum Pharmaceuticals Announces Primary Endpoint Met in Phase 2b Portion of the AZURE-1 Study of Brelovitug in Chronic Hepatitis Delta Virus
Mar 16, 2026 08:00AM
Mar 16, 2026 08:00AM
Mar 5, 2026 08:00AM
Feb 26, 2026 04:49AM
Feb 25, 2026 04:01PM
Feb 5, 2026 08:52AM
Feb 5, 2026 08:51AM Mirum Pharmaceuticals Announces Health Canada Authorization of LIVMARLI® Tablet Formulation for the Treatment of Cholestatic Pruritus in Patients with Alagille Syndrome
Feb 5, 2026 08:01AM
Feb 5, 2026 08:00AM
Jan 26, 2026 08:00AM
Jan 26, 2026 08:00AM
Jan 12, 2026 08:31AM
Jan 12, 2026 08:30AM
Dec 19, 2025 04:08PM Mirum sues generic drugmakers over Livmarli patent infringement
Dec 19, 2025 09:06AM
Dec 9, 2025 06:54AM
Dec 8, 2025 03:01PM
Dec 8, 2025 08:00AM
Dec 8, 2025 08:00AM
Nov 25, 2025 04:02PM
Nov 10, 2025 08:00PM Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Nov 7, 2025 08:11AM
Nov 7, 2025 08:10AM
Nov 4, 2025 04:01PM
Nov 3, 2025 04:05PM
Oct 28, 2025 04:02PM
Oct 10, 2025 07:45PM
Sep 10, 2025 06:45PM Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Sep 8, 2025 08:00AM

325,887 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All